Trials / Conditions / X-linked Agammaglobulinemia
X-linked Agammaglobulinemia
7 registered clinical trials studyying X-linked Agammaglobulinemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | COVID-19 Vaccine Responses in PIDD Subjects NCT05321407 | Duke University | — |
| Terminated | Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older NCT02960399 | University of South Florida | N/A |
| Active Not Recruiting | Immune Disorder HSCT Protocol NCT01821781 | Washington University School of Medicine | Phase 2 |
| Completed | A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency NCT01289847 | Bio Products Laboratory | Phase 4 |
| Completed | Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy NCT00542997 | CSL Behring | Phase 3 |
| Terminated | Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies NCT00006054 | Fairview University Medical Center | N/A |
| Unknown | Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders NCT00004341 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | — |